Navigation Links
New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp
Date:6/23/2009

MEMPHIS, Tenn., June 24 /PRNewswire/ -- The Theraplex Company, makers of the Theraplex line of medical moisturizers, unveiled the new theraplex SA FACIAL PEEL last week at the Cosmetic Boot Camp in Aspen, Colorado. It sparked a lot of excitement among dermatologists attending the camp.

The new peel is an in-office, superficial salicylic acid peel treatment available in 25% and 30% concentrations. This versatile skin procedure can be used on all skin types to improve the appearance of acne prone and photo-damaged skin and has a visible impact on melasma and post-inflammatory hyperpigmentation.

Theraplex SA Facial Peel is packaged in a convenient, easy-to-use kit, which includes theraplex HYDROLOTION. This noncomedogenic, hypoallergenic, daily skin moisturizer restores moisture and protects your skin's natural barrier from the harsh effects of the environment.

"I was glad to see the new theraplex SA FACIAL PEELs at the recent Cosmetic Boot Camp," said Vic A. Narurkar, MD, Chief of Dermatology at California Pacific Medical Center. "I use salicylic acid peels on patients with all skin types because they're effective, easy to administer, have an excellent safety record, and there's virtually no patient down time."

The new theraplex SA FACIAL PEEL kits will be priced at $18.50 per kit, with additional introductory discount offers, which make these kits an exceptional value.

"We're pleased to be able to offer the medical community a cost effective and convenient salicylic acid peel," said Mike Pietrangelo, managing partner of The Theraplex Company, LLC.

Theraplex SA FACIAL PEELS are available only through medical professionals. The Theraplex line of moisturizers is available behind the pharmacy counter at major retail pharmacies, such as Walgreens, CVS and Rite-Aid, as well as independent pharmacies. No prescription is necessary
'/>"/>

SOURCE The Theraplex Company, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Prepare to Unveil Yourself with Theraplex(R) for Spring and Summer 2008
2. National Eczema Association Anoints Theraplex Child-Friendly Eczema Products with Seal of Acceptance
3. National Eczema Association Anoints Theraplex Products with Seal of Acceptance
4. In-the-Field Facial Surgery Helps Injured Troops in Iraq
5. Facial expressions have greater impact on kids with bipolar disorder
6. Facial Deformity Danger?
7. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
8. Breakthrough Acai Berry Anti-Aging Facial Applies Benefits of Natures Super-Food to the Skin
9. Facial asymmetry persists despite surgery to correct congenital deformity
10. African Americans Show Facial Aging in Eyes Earlier Than Caucasians
11. Body identification by facial reconstruction will cost less time and money
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Deer Path of ... host a Valentine’s Day Happy Hour from 3 p.m. to 4 ... 12500 Regency Parkway in Huntley, Illinois, serves adults with physical disabilities ... event will include Valentine's Day treats, games and sweetheart-themed karaoke. , ...
(Date:1/22/2015)... PA (PRWEB) January 22, 2015 Woodloch Pines, ... Mountains, has been selected by TripAdvisor as the number one ... the 6th best in the world for their annual Travelers’ ... online travel community . The website is home to millions ...
(Date:1/22/2015)... January 23, 2015 Angelweddingdress is a famous ... invites its customers to follow it on Facebook, Twitter, and ... Valentine’s Day gift. Angelweddingdress draws a lottery every week. , ... to Feb. 28, 2015. Click Angelweddingdress homepage for ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A new ... of experience and person-centeredness in the long-term care environment ... action across the continuum. The paper, “The Power of ... engages perspectives and practices of the patient, resident and ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television ... 32nd Annual Miami Breast Cancer Conference planned ... (PER®) , shares that “a fast-growing, virulent” cancer in ... had not followed up her clean mammogram with an ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... given to nurse practitioners conducting outstanding research in ... ... Mission Pharmacal today,congratulated the winners of the National Association of Nurse,Practitioners ... Conference in Philadelphia, Pennsylvania. The,awards are given to the authors of ...
... CYNO ), a leading developer and manufacturer ... today announced that the company,will host its third-quarter ... 9:00 a.m. ET. On the call, President ... President and Chief Financial Officer Timothy Baker will,discuss ...
... They Are More Adventurous and Willing to ... They Were in Their 20s, - Boomers Can Stay On-the-Go with ... a recent study, sixty-,four percent of baby boomers claim they feel ... half (48 percent) say they are more,adventurous and willing to experiment ...
... Micromet, Inc.,(Nasdaq: MITI ), a biopharmaceutical ... products for the treatment of cancer,inflammatory and autoimmune ... an Investigational Medicinal Product Dossier (IMPD),for the conduct ... in patients with,acute lymphoblastic leukemia (ALL) in Germany. ...
... for Third Consecutive Quarter, DEERFIELD, Ill., Oct. 18 ... strong financial results for the period,ended September 30, 2007 ... Third quarter net income of $395 million increased ... quarter of 2006. Net earnings per,diluted share of $0.61 ...
... 18 While shopping is usually viewed as,a ... shopper in twenty, the,habit is a process addiction. ... than holiday buying and trying on new work ... that can spiral into financial and,emotional disaster. ...
Cached Medicine News:Health News:Mission Pharmacal Congratulates Exemplary Women's Health Researchers 2Health News:Mission Pharmacal Congratulates Exemplary Women's Health Researchers 3Health News:Mission Pharmacal Congratulates Exemplary Women's Health Researchers 4Health News:Mission Pharmacal Congratulates Exemplary Women's Health Researchers 5Health News:Mission Pharmacal Congratulates Exemplary Women's Health Researchers 6Health News:Mission Pharmacal Congratulates Exemplary Women's Health Researchers 7Health News:Cynosure to Announce Third-Quarter 2007 Financial Results on November 1 2Health News:Forget the 'Old' Stereotypes - New Survey Reveals that Baby Boomers Are Feeling More 'Young' and Active than Ever! 2Health News:Forget the 'Old' Stereotypes - New Survey Reveals that Baby Boomers Are Feeling More 'Young' and Active than Ever! 3Health News:Forget the 'Old' Stereotypes - New Survey Reveals that Baby Boomers Are Feeling More 'Young' and Active than Ever! 4Health News:Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia 2Health News:Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia 3Health News:Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia 4Health News:Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia 5Health News:Baxter Reports Strong Third Quarter Sales and Earnings 2Health News:Baxter Reports Strong Third Quarter Sales and Earnings 3Health News:Baxter Reports Strong Third Quarter Sales and Earnings 4Health News:Baxter Reports Strong Third Quarter Sales and Earnings 5Health News:Baxter Reports Strong Third Quarter Sales and Earnings 6Health News:Baxter Reports Strong Third Quarter Sales and Earnings 7Health News:Baxter Reports Strong Third Quarter Sales and Earnings 8Health News:Baxter Reports Strong Third Quarter Sales and Earnings 9Health News:Baxter Reports Strong Third Quarter Sales and Earnings 10Health News:Baxter Reports Strong Third Quarter Sales and Earnings 11Health News:Baxter Reports Strong Third Quarter Sales and Earnings 12Health News:Baxter Reports Strong Third Quarter Sales and Earnings 13Health News:Baxter Reports Strong Third Quarter Sales and Earnings 14Health News:Baxter Reports Strong Third Quarter Sales and Earnings 15Health News:Baxter Reports Strong Third Quarter Sales and Earnings 16Health News:Baxter Reports Strong Third Quarter Sales and Earnings 17Health News:Baxter Reports Strong Third Quarter Sales and Earnings 18Health News:Baxter Reports Strong Third Quarter Sales and Earnings 19Health News:Baxter Reports Strong Third Quarter Sales and Earnings 20Health News:Baxter Reports Strong Third Quarter Sales and Earnings 21Health News:Baxter Reports Strong Third Quarter Sales and Earnings 22
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)... Inc., a leader in hand hygiene monitoring, today announced ... subsidiary of Ascendis Health Limited, in Johannesburg, ... of millions of patients around the world are affected ... patient to patient via the unwashed hands of healthcare ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... April 28 The biopharma mega-mergers that grabbed headlines last year ... are now in the critical post-integration period and the acquiring companies are ... too early for final verdicts, but clearly one M&A issue that continues ... , , , ...
... DAYTONA BEACH, Fla. and MT. LAUREL, N.J. , ... part of its "First Time Right" quality service initiative, MedQuist ... clinical documentation services, will begin offering BenchMark KB ... users, during Q210.  BenchMark KB, created by InterFix LLC, is ...
Cached Medicine Technology:Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence 2Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence 3MedQuist Launches BenchMark KB(R) Knowledge Base 2MedQuist Launches BenchMark KB(R) Knowledge Base 3MedQuist Launches BenchMark KB(R) Knowledge Base 4MedQuist Launches BenchMark KB(R) Knowledge Base 5
The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incub...
... The GenoSensor System includes genomic ... software, and reagents. By utilizing ... (CGH) technology for multi-target assessment, ... analyze multiple genomic targets in ...
The ABI PRISM 3100 Genetic Analyzer, a multi-color fluorescence-based DNA analysis system with 16 capillaries operating in parallel, offers high-quality data and efficient sample processing for the b...
... latest 3-part differential analyzer based on the ... the CELL-DYN line. Offering 18 parameters and ... CELL-DYN 1800 meets the needs to today's ... than its predecessors and fits under standard ...
Medicine Products: